Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital app may bring lung rehab to local clinics

NCT ID NCT07687836

Knowledge-focused Sponsor: ADIR Association Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study looks at whether a digital tool called TELEREHAPP can help physiotherapists in private clinics provide pulmonary rehabilitation for people with chronic lung diseases like COPD. Researchers will analyze data already collected from physiotherapists and patients to see how often the tool was used, how easy it was to use, and whether patients showed any improvement. The goal is to find new ways to make lung rehab more accessible outside of specialized centers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TELEREHAPP digital application
What this could lead to
If successful, this could show that a simple digital tool helps more people with lung disease access rehabilitation closer to home.
What could go wrong
This is a small, retrospective study without a control group, so it cannot prove the tool improves health outcomes. Results may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients with chronic respiratory diseases.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age superior to 18 years; * Referred for pulmonary rehabilitation in private physiotherapy practice. Non-inclusion Criteria: \- Not applicable Exclusion Criteria: \- Not applicable

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Respiration Disorders respiratory system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease (COPD) Chronic respiratory diseases Pulmonary rehabilitation Respiration disorders

Contacts and locations

Locations

  • ADIR Association

    Rouen, 76000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.